Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

¥13.71As of Sun 8 Nov 2026, 12:00 UTC
SSE:603896Healthcare
Country China
PE (Fwd) •••
TSR 9Y CAGR (8.60%)
Div yield —
ROE (0.77%)
Biotechnology
Beta (5Y) 0.32
PE TTM —
TSR TTM (32.26%)
Mkt cap ¥2.718B
ROIC (1.34%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥15
9.99%
(53.35%)
Hold 4|11|9|2|7
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.17
0.16
0.18
0.20
12.36%
7.18%
21.57%
31.14%
Revenue¥M
181.6
181.5
183.8
191.2
4.06%
1.00%
0.53%
4.43%
Peers (US$407.4M)
Cap (US$)
PE
407.0M
—
Capital
TTM
5Y
10Y
Leveragex
0.338
(0.044)
(0.039)
EBIT/Intx
1.420
0.105
0.127
Own earn%
1.64
75.58
43.25
Sh yield%
39.51
29.39
24.12
Owners
Insiders/Inst%
7.56
31.15
Short interest%
5.17
SBC / revenue%
3.84
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
15–22
$1 testx
—
Incr. ROIC%
13